Publications by authors named "A Katanuma"
Article Synopsis
- Major hepatectomy (MH) can lead to a higher risk of adverse events due to reduced liver function and surgical impact, prompting an analysis within the JCOG1113 trial focused on gemcitabine-based treatments for advanced biliary tract cancer.* -
- Among 354 patients, 76 were evaluated post-surgery for recurrence; results indicated that while platelet counts fell more in patients who underwent MH, anemia and white blood cell count decreases were less frequent compared to those who did not have MH.* -
- Overall survival rates were similar between MH and non-MH patients receiving gemcitabine with both S-1 and cisplatin, suggesting that gemcitabine-based chemotherapy maintains its safety and efficacy
Article Synopsis
- *The Subcommittee defined five types of I-EUS procedures based on their purpose and method: EUS-guided sampling, EUS-guided through-the-needle examination, EUS-guided drainage/anastomosis, ESCR procedures, and EUS-guided delivery.
- *The proposed classifications aim to clarify I-EUS procedures and will be updated as new techniques and concepts arise in the field.*
Objectives: Unresectable ampullary cancer (AC) is a rare disease entity. The risk factors for recurrent biliary obstruction (RBO) following endoscopic biliary stenting (EBS) for unresectable AC remain unknown. In this study we aimed to evaluate the cumulative RBO rate and to identify risk factors for RBO following palliative EBS in patients with unresectable AC.
View Article and Find Full Text PDF